Your browser doesn't support javascript.
loading
Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.
Escherich, Gabriele; Zur Stadt, Udo; Borkhardt, Arndt; Dilloo, Dagmar; Faber, Jörg; Feuchtinger, Tobias; Imschweiler, Thomas; Jorch, Norbert; Pekrun, Arnulf; Schmid, Irene; Schramm, Franziska; Spohn, Michael; Zimmermann, Martin; Horstmann, Martin A.
Afiliação
  • Escherich G; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg. escherich@uke.de.
  • Zur Stadt U; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg.
  • Borkhardt A; Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty Duesseldorf, Duesseldorf.
  • Dilloo D; Department of Pediatric Hematology/Oncology, University Hospital Bonn, Bonn.
  • Faber J; Department of Pediatric Hematology/Oncology, University Hospital Mainz, Mainz.
  • Feuchtinger T; Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich.
  • Imschweiler T; Department of Pediatric Hematology and Oncology, Helios Hospital, Krefeld.
  • Jorch N; Department of Pediatric Hematology and Oncology, Protestant Hospital of Bethel Foundation, Bielefeld.
  • Pekrun A; Department of Pediatric Hematology and Oncology, Hospital Bremen-Mitte.
  • Schmid I; Dr. von Hauner Children's Hospital, Ludwig Maximilian University, Munich.
  • Schramm F; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg.
  • Spohn M; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children's Cancer Center Hamburg, Germany; Bioinformatics Core Unit, University Medical Center Hamburg.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Medical School Hannover, Hannover.
  • Horstmann MA; Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Research Institute Children's Cancer Center Hamburg. horstmann@uke.de.
Haematologica ; 107(5): 1026-1033, 2022 05 01.
Article em En | MEDLINE | ID: mdl-34348455
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma não Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Haematologica Ano de publicação: 2022 Tipo de documento: Article